Dishman NL to bring HPAPI Development Opportunities to CPhl Worldwide Forum

Press Release – Dishman Netherlands B.V
Dishman NL to bring HPAPI Development Opportunities to CPhl Worldwide Forum

Dishman Logo

Contact Supplier: Dishman Netherlands B.V
Supplier Press Release: Dishman NL to bring HPAPI Development Opportunities to CPhl Worldwide Forum
Address: Nieuweweg 2a, 3901 BE Veenendaal, Netherlands
Tel: +31 318 545 754
Fax: +31 318 529 374
Website: www.dishman-netherlands.com

OCTOBER 08, 2013

Dishman NL to bring HPAPI Development Opportunities to CPhl Worldwide Forum

Veenendaal, Netherlands: – Respected active pharmaceutical ingredient developer Dishman Netherlands BV (Dishman NL) will use the sophisticated partnering arrangements at CPhI Worldwide 2013, on 22-24 October at Messe Frankfurt to seek new partners for its highly potent active pharmaceutical ingredient (HPAPI) development and manufacturing services.

This will be the 7th time that Dishman NL has attended the CPhl conference, which has become a premier European networking and partnering event, bringing together over 30,000 attendees from 140 countries, along with 2,200 exhibitors. Dishman will be using the CPhI Global Meetings programme to identify potential partners interested in harnessing Veenendaal’s world-class capabilities.

Dishman will also be present at Stand 50D22 at the CPhl Ingredients Exhibition in Hall 5.0, where it will showcase its sophisticated HPAPI supply capabilities plus supporting services like route synthesis optimization and analytical method development.

Sophisticated capabilities
Dishman NL is a contract research and manufacturing (CRAM) organisation that delivers process research services to support the development of new products, offering research and manufacturing packages ranging from mg through 25 kg commercial scale batch sizes with optional intercompany upscaling to multi ton batches. All these services are carried out in cGMP-compliant laboratory and production facilities, which are also ISO 9001 and ISO 14001 certified. The company is able to handle highly potent materials and can offer column chromatography, UV photochemistry, saponification, liquid extraction and other advanced research technologies.

The company’s employees are specialists in producing high quality Vitamin D3 derived active ingredients, used in treatment of such illnesses as psoriasis, osteoporosis, and rickets.

The Dishman NL team at CPhl Worldwide will also be able to present the company’s impressive track record of managing successful projects in liaison with customers, as well as its abilities to work with market experts to develop high quality specific application formulations for its lanolin alcohol, and cholesterol products.

Dr. Henk Pluim, Dishman NL’s CEO, said CPhl Worldwide had become a central event in the company’s calendar.

“Our attendance last year was highly successful in identifying organisations that were impressed by our capabilities and interested in working with us. Essentially, most of the companies that can benefit from our capabilities are likely to be at Messe Frankfurt,” said Dr Pluim.

“The Dishman Group will be looking to talk to anyone that needs HIPO APIs developed and produced to specialised requirements, from milligram to multi-tonne scales, and using cGMP compliant in-house facilities,” he added.

“We typically value supportive services like route synthesis optimization, analytical method development, as well as flexible business approaches, based on risk sharing.”

Dishman NL is inviting potential collaborators to contact the company directly or via the CPhI Worldwide system, which is already open.

About Dishman NL
Dishman Netherlands BV (Dishman NL) is active in the manufacture, marketing and sales of Vitamin D analogues, Vitamin D, Cholesterol and Lanolin related products. The company’s products are in demand in pharmaceutical, and other key markets, including cosmetics, catering, animal feeds, shrimp farming and industrial applications.

The company is an important member of Dishman Group, a dynamic global, group of companies offering a spectrum of services to the pharmaceutical industry. Dishman is a global outsourcing partner for pharma companies, offering a portfolio of products and development, scale-up and manufacturing services.

A core component of Dishman NL’s mission is efficient production that is also safe, responsible and environmentally sustainable. The Company aims for high efficiency and effectiveness through close collaboration between its people, suppliers and customers. Dishman prides itself on open communication with all stakeholders.

Dishman NL offers a range of specialist and value added services. These include:

Contract Research: Dishman NL delivers process research services to support the transfer of new products. It offers research on all unit operations that are available in its facility on production scale. Typical batch sizes range from 10 mg (laboratory scale) to 25 kg (commercial scale). All research s performed in cGMP compliant laboratories. The company is able to handle highly potent materials and can offer column chromatography, UV photochemistry, saponification, liquid extraction and other advanced research technologies.

Contract Manufacturing: Dishman can carry out contract manufacturing at its modern ISO 9001 and ISO 14001 certified facility at Veenendaal in central Holland. For high criticality orders, Dishman can produce under cGMP and handle high potency materials. The company’s highly skilled activity transfer team has a proven track record of managing successful projects in liaison with customers. The manufacturing operation has access to the same range of advanced technologies as the contract research laboratory, including continuous process saponification, stainless steel reactors, and crystallization, drying, milling, mixing and solvent recovery apparatus.

Formulations: Dishman NL works with leading cosmetics experts to develop high quality specific application formulations for its lanolin alcohol, and cholesterol products.

About CPhl Worldwide
CPhI Worldwide bills itself as ‘the number one Pharma sourcing event’, offering delegates opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.

The 2013 event is being held from October 22-24 at Messe Frankfurt and will host more than 30,000 delegates from 140 countries along with 2,200 exhibitor companies.

The CPHl Ingredients show is being held alongside three other zoned exhibitions; CPhl Ingredients, ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.

The Pre-Connect Conference on October 21 comprises six modules on current industry ‘hot topics’ offering themed networking opportunities.

CPhl is staged by UBM Live, the leading Global B2B Events Organisers and Publishers.

Contact:
Evert Drewes
Marketing & Sales Manager
Tel: +31 318 545 754
Email:info@dishman-netherlands.com

For more information about Dishman’s highly potent active pharmaceutical ingredient (HPAPI) development and manufacturing services, please contact Dishman NL directly

Comments are closed.